Iradimed Corp. (IRMD) Tops Q3 EPS by 3c

Iradimed Corp. (NASDAQ: IRMD) reported Q3 EPS of $0.19, $0.03 better than the analyst estimate of $0.16. Revenue for the quarter came in at $8.2 million versus the consensus estimate of $7.7 million.

For earnings history and earnings-related data on Iradimed Corp. (IRMD) click here.

You May Also Be Interested In

• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• SanDisk (SNDK) PT Raised to $3,000 at Bernstein SocGen Group, 'We believe this is not understood by the Street'
• After-Hours Stock Movers: AVAV, PRAX, VSH, CNXC, SHAZ